The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Accessed Sept, 5 2018
Weekly epidemiological record, Relevé épidémiologique hebdomadaire : Vol.93 (2018) No.13
El maltrato infantil ha pasado a considerarse en la última década un problema de salud pública. Numerosos trabajos que analizan los efectos directos en la salud mental infantil informan de una alta prevalencia en alteraciones internalizantes, externalizantes y en trastorno por estrés postraumát...ico (TEPT). La Terapia Cognitivo Conductual-Focalizada en el Trauma ha sido la única que ha recibido la mención de tratamiento eficaz bien establecido en población infanto-juvenil. La técnica de exposición prolongada se considera de elección para el tratamiento del TEPT, si bien numerosos pacientes presentan dificultades para llevarla a cabo. La realidad virtual se ha convertido en una alternativa que facilita la técnica de exposición..
more
Communicable Disease Control Branch
Communicable Disease Management Protocol – Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS), February 2010
Mid-term review of The National AIDS Programme 2011-15
October 2013
Geneva, Switzerland 9th March 2016
Putting Asia’s HIV response back on track
UNAIDS Joint United Nations Programme on HIV/AIDS
Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation
Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation
The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of the WHO consolidated TB guidelines, this handbook... will be the first in a modular series of practical guides meant for the implementers of various aspects of the programmatic management TB.
more
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...that are intended for widespread utility throughout sub-Saharan Africa for treatment of envenoming irrespective of the species of snake causing a bite. Monovalent antivenoms for specific use cases: for products for a single species (or genus) of snake (e.g., boomslangs or carpet viper antivenoms).
Syndromic Pan-African polyvalent antivenoms for neurotoxic envenoming: products that are intended for treatment of envenoming by species whose venoms are neurotoxic. Syndromic Pan-African polyvalent antivenoms for non-neurotoxic envenoming: products for snakebite envenoming where the effects are largely haemorrhagic, necrotic or procoagulant.
more
Standard Treatment Guideline